edrophonium has been researched along with Coronary Disease in 9 studies
Edrophonium: A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.
edrophonium : A quaternary ammonium ion that is N-ethyl-N,N-dimethylanilinium in which one of the meta positions is substituted by a hydroxy group. It is a reversible inhibitor of cholinesterase, with a rapid onset (30-60 seconds after injection) but a short duration of action (5-15 minutes). The chloride salt is used in myasthenia gravis both diagnostically and to distinguish between under- or over-treatment with other anticholinesterases. It has also been used for the reversal of neuromuscular blockade in anaesthesia, and for the management of poisoning due to tetrodotoxin, a neuromuscular blocking toxin found in puffer fish and other marine animals.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ten patients with anginal symptoms and ergonovine-induced chest pain without coronary artery spasm had esophageal manometry with provocative pharmacologic testing." | 7.66 | Provocation of esophageal pain by ergonovine or edrophonium. ( Cohen, S; Goldberg, S; Hirshfeld, JW; London, RL; Ouyang, A; Snape, WJ, 1981) |
| "Ten patients with anginal symptoms and ergonovine-induced chest pain without coronary artery spasm had esophageal manometry with provocative pharmacologic testing." | 3.66 | Provocation of esophageal pain by ergonovine or edrophonium. ( Cohen, S; Goldberg, S; Hirshfeld, JW; London, RL; Ouyang, A; Snape, WJ, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| London, RL | 1 |
| Ouyang, A | 1 |
| Snape, WJ | 1 |
| Goldberg, S | 1 |
| Hirshfeld, JW | 1 |
| Cohen, S | 1 |
| Hookman, P | 1 |
| Barkin, JS | 1 |
| Jaklitsch, MT | 1 |
| Byrne, JG | 1 |
| Mery, C | 1 |
| Kooguchi, K | 1 |
| Maegawa, Y | 1 |
| Namba, M | 1 |
| Yaku, H | 1 |
| Takahashi, A | 1 |
| Tanaka, Y | 1 |
| Rossen, RM | 1 |
| Krikorian, J | 1 |
| Hancock, EW | 1 |
| Meesmann, M | 1 |
| Karagueuzian, HS | 1 |
| Ino, T | 1 |
| McGrath, MF | 1 |
| Mandel, WJ | 1 |
| Deschner, WK | 1 |
| Maher, KA | 1 |
| Cattau, EL | 1 |
| Benjamin, SB | 1 |
| Hewson, EG | 1 |
| Dalton, CB | 1 |
| Hackshaw, BT | 1 |
| Wu, WC | 1 |
| Richter, JE | 1 |
| Harrison, LA | 1 |
| Harrison, LH | 1 |
| Kent, KM | 1 |
| Epstein, SE | 1 |
1 trial available for edrophonium and Coronary Disease
| Article | Year |
|---|---|
[Heart rate reduction using edrophonium during coronary artery bypass grafting without cardiopulmonary bypass].
Topics: Aged; Aged, 80 and over; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Disease; Edrophoni | 2000 |
8 other studies available for edrophonium and Coronary Disease
| Article | Year |
|---|---|
Provocation of esophageal pain by ergonovine or edrophonium.
Topics: Adult; Angina Pectoris; Coronary Disease; Diagnosis, Differential; Edrophonium; Ergonovine; Esophage | 1981 |
The diagnosis and management of unexplained chest pain--is less more?
Topics: Angina Pectoris; Chest Pain; Coronary Angiography; Coronary Disease; Diagnosis, Differential; Edroph | 1999 |
Thymoma encasing last patent vein graft to the heart.
Topics: Combined Modality Therapy; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Edrophoni | 1999 |
Ventricular asystole after edrophonium chloride administration.
Topics: Aged; Arrhythmias, Cardiac; Autopsy; Coronary Disease; Edrophonium; Electrocardiography; Female; Hea | 1976 |
The role of enhanced vagal activity on ischemic ventricular tachycardia: pharmacologic basis of inefficiency.
Topics: Adrenergic beta-Antagonists; Animals; Atropine; Cardiac Pacing, Artificial; Coronary Circulation; Co | 1991 |
Intraesophageal balloon distention versus drug provocation in the evaluation of noncardiac chest pain.
Topics: Bethanechol; Bethanechol Compounds; Catheterization; Chest Pain; Coronary Disease; Deglutition Disor | 1990 |
The prevalence of abnormal esophageal test results in patients with cardiovascular disease and unexplained chest pain.
Topics: Acids; Adult; Aged; Angioplasty, Balloon; Cardiovascular Diseases; Chest Pain; Coronary Artery Bypas | 1990 |
Enhancement of electrical stability of acutely ischemic myocardium by edrophonium.
Topics: Acetylcholine; Animals; Arrhythmias, Cardiac; Atropine; Cholinesterase Inhibitors; Coronary Disease; | 1974 |